Australian Pharmaceutical Industries Ltd
ASX:API

Watchlist Manager
Australian Pharmaceutical Industries Ltd Logo
Australian Pharmaceutical Industries Ltd
ASX:API
Watchlist
Price: 1.53 AUD
Market Cap: 753.8m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+308%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

API Price Targets Summary
Australian Pharmaceutical Industries Ltd

There are no price targets for API.
API Lowest Forecast
Wall Street Target
Not Available
API Average Forecast
Wall Street Target
Not Available
API Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Australian Pharmaceutical Industries Ltd Competitors:
Price Targets
EBO
EBOS Group Ltd
15% Upside
COR
Cencora Inc
9% Upside
HSIC
Henry Schein Inc
9% Upside
EBO
EBOS Group Ltd
15% Upside
COR
Cencora Inc
9% Upside
HSIC
Henry Schein Inc
9% Upside

Revenue
Forecast

Revenue Estimate
Australian Pharmaceutical Industries Ltd

For the last 8 years the compound annual growth rate for Australian Pharmaceutical Industries Ltd's revenue is 3%. The projected CAGR for the next 2 years is -17%.

3%
Past Growth
-17%
Estimated Growth
Estimates Accuracy
50%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Australian Pharmaceutical Industries Ltd

Operating Income forecast
is not available for
Australian Pharmaceutical Industries Ltd

Net Income
Forecast

Net Income Estimate
Australian Pharmaceutical Industries Ltd

For the last 8 years the compound annual growth rate for Australian Pharmaceutical Industries Ltd's net income is -30%. The projected CAGR for the next 2 years is 406%.

-30%
Past Growth
406%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
API intrinsic value, competitors valuation, and company profile.
DCF Valuation
API stock valuation using Discount Cash Flow valuation method.
Relative Valuation
API stock valuation using valuation multiples.
Wall Street Estimates
API price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
API stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is API's stock price target?
Not Available

API doesn't have any price targets made by Wall Street professionals.

What is Australian Pharmaceutical Industries Ltd's Revenue forecast?
Projected CAGR
-17%

For the last 8 years the compound annual growth rate for Australian Pharmaceutical Industries Ltd's revenue is 3%. The projected CAGR for the next 2 years is -17%.

What is Australian Pharmaceutical Industries Ltd's Net Income forecast?
Projected CAGR
406%

For the last 8 years the compound annual growth rate for Australian Pharmaceutical Industries Ltd's net income is -30%. The projected CAGR for the next 2 years is 406%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 262,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.